Q2 2023 Pharming Group NV Earnings Call Transcript
Good morning or good afternoon all, and welcome to Pharming's First Half 2023 Results Call. My name is Adam, and I will be your operator for today. (Operator Instructions)
I will now hand the floor over to Sijmen de Vries to begin. So Sijmen, please go ahead when you're ready.
Thank you very much, Adam. Good morning or good afternoon, ladies and gentlemen. Welcome to our second quarter and first half 2023 financial results call.
Next slide, please. I'm here with my 3 colleagues, Dr. Anurag Relan, our Chief Medical Officer; Stephen Toor, our Chief Commercial Officer; and Jeroen Wakkerman, our Chief Financial Officer, to take you through the highlights of these results and, of course, to answer all your questions that you may have afterwards.
But before I do that, of course, I would like to point you to the next slide that says something about forward-looking statements because we will be making some forward-looking statements, of course, today, that are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
